NOT-DA-19-056: Notice of Correction to PAR-19-162, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)"

Notice of Correction to PAR-19-162, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)"

Notice Number: NOT-DA-19-056

Key Dates
Release Date: June 17, 2019

Related Announcements
PAR-19-162

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to remove NICHD information from the Purpose section of this FOA.

Removed language:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Purpose

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

The mission of NICHD is to support biomedical, biobehavioral and social science studies on the processes of human development. For this FOA, NICHD is particularly interested in applications that use the ABCD Study data to characterize typical neurobehavioral trajectories of affective, cognitive and social function across development and how environmental experiences can affect those trajectories. In addition, the NICHD wishes to highlight for this FOA examinations of neurocognition and language use among individuals who are bilingual, and studies of neurobehavioral and social development of individuals with learning disabilities.

As specified in Components of Participating Organizations, NICHD does not participate in this FOA.

Inquiries

Please direct all inquiries to:

Karen Sirocco
National Institute on Drug Abuse (NIDA)
Telephone:301-451-8661
Email: siroccok@nida.nih.gov